COMPOSITION | |
---|---|
Imipenem | 500MG |
Cilastatin | 500MG |
Imipenem Cilastatin
IMIVIB
DESCRIPTION
Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with cilastatin, a renal dipeptidase inhibitor. [PubChem]
SIDE EFFECTS
N/A
INDICATION
For the treatment of bacterial infections caused by susceptible bacteria.